We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MLTX market cap is 2.54B. The company's latest EPS is USD -1.9302 and P/E is -20.54.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -15.03M | -19.82M | -30.58M | -43.11M | -49.58M |
| Net Income | -7.89M | -13.98M | -23.97M | -35.39M | -50.22M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -106k | -4.57M | -65.06M | -54.12M | -143.09M |
| Net Income | -91k | -4.54M | -64.51M | -44.08M | -123.55M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 526.54M | 564.12M | 544.88M | 518.21M | 477.93M |
| Total Liabilities | 13.05M | 11.73M | 14.85M | 22.71M | 24.54M |
| Total Equity | 513.49M | 552.39M | 530.03M | 495.5M | 453.39M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 116.63M | 115.84M | 76.84M | 526.54M | 477.93M |
| Total Liabilities | 4.15M | 7.9M | 8.08M | 13.05M | 24.54M |
| Total Equity | 5M | -7.06M | 68.77M | 513.49M | 453.39M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -42.78M | -14.95M | -42.84M | -68.11M | -116.59M |
| Investing | -25.19M | -28.8M | -116.55M | -58.27M | -205.6M |
| Financing | 479.7M | 50.98M | 50.98M | 51.16M | 51.31M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -317k | -611k | -55.89M | -42.78M | -116.59M |
| Investing | -115M | N/A | -32.34M | -25.19M | -205.6M |
| Financing | 116.65M | -58k | 119.69M | 479.7M | 51.31M |
| Market Cap | 2.54B |
| Price to Earnings Ratio | -20.54 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 14.07 |
| Price to Book Ratio | 5.6 |
| Dividend Yield | - |
| Shares Outstanding | 64.01M |
| Average Volume (1 week) | 491.72k |
| Average Volume (1 Month) | 371.12k |
| 52 Week Change | -18.33% |
| 52 Week High | 58.26 |
| 52 Week Low | 36.52 |
| Spread (Intraday) | 1.54 (3.81%) |
| Company Name | MoonLake Immunotherapeutics |
| Address |
p.o. box 309 grand cayman 1104 |
| Website | https://moonlaketx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
